Covestor’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17K Sell
201
-212
-51% -$18.9K 0.01% 1172
2025
Q4
$33K Sell
413
-2
-0.5% -$157 0.02% 1057
2025
Q3
$33K Sell
415
-47
-10% -$4.01K 0.02% 1080
2025
Q2
$42K Sell
462
-3
-0.6% -$274 0.02% 959
2025
Q1
$44K Buy
465
+34
+8% +$3.04K 0.03% 887
2024
Q4
$39K Buy
431
+100
+30% +$9.54K 0.02% 942
2024
Q3
$34K Sell
331
-96
-22% -$9.79K 0.02% 1012
2024
Q2
$41K Sell
427
-588
-58% -$54.2K 0.03% 939
2024
Q1
$91K Buy
1,015
+215
+27% +$18.2K 0.06% 604
2023
Q4
$64K Sell
800
-623
-44% -$46.8K 0.04% 741
2023
Q3
$101K Buy
1,423
+438
+44% +$32.7K 0.08% 407
2023
Q2
$76K Buy
985
+631
+178% +$48.8K 0.06% 592
2023
Q1
$27K Buy
354
+36
+11% +$2.68K 0.02% 911
2022
Q4
$25K Sell
318
-5
-2% -$375 0.02% 966
2022
Q3
$23K Sell
323
-1,981
-86% -$155K 0.02% 957
2022
Q2
$185K Sell
2,304
-147
-6% -$11.5K 0.15% 131
2022
Q1
$186K Buy
2,451
+1,025
+72% +$81.2K 0.12% 175
2021
Q4
$122K Buy
+1,426
New +$111K 0.17% 93

Other funds holding CL

Covestor's CL Position: Q1 2026 in Review

Covestor reduced its Colgate-Palmolive (CL) stake by 51% in Q1 2026, selling an estimated $18.9K and leaving 201 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #1172.

Covestor first reported a position in CL in Q4 2021 and has held it in 18 quarters since. The position peaked at $186K in Q1 2022. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Covestor held 201 shares of Colgate-Palmolive worth $17K as of Q1 2026.
  • Covestor sold 212 Colgate-Palmolive shares in Q1 2026, an estimated $18.9K.
  • Colgate-Palmolive made up 0.01% of Covestor's portfolio in Q1 2026, its #1172 holding.
  • Covestor first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Colgate-Palmolive position peaked at $186K in Q1 2022.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.